The COL1A1 gene mutations have documented important roles in a range of diseases, with particular focus on bone and connective tissue diseases, in particular osteogenesis imperfecta and Ehlers–Danlos syndrome (Table 1). This evidence concerns the gene COL1A1 and osteogenesis imperfecta.